» Articles » PMID: 22993347

Association of Syndecan-1 with Angiogenesis-related Markers, Extracellular Matrix Components, and Clinicopathological Features in Colorectal Carcinoma

Overview
Journal Anticancer Res
Specialty Oncology
Date 2012 Sep 21
PMID 22993347
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Syndecan-1 is a transmembrane heparansulfate proteoglycan, which regulates cell proliferation, migration, angiogenesis, cell-to-cell and cell-to-extracellular matrix adhesion and may influence malignant cell behavior. We investigated the alterations of syndecan-1 expression in colorectal cancer and analyzed the relationship between clinicopathological parameters, proliferation indices, angiogenic markers, and extracellular matrix components. Syndecan-1 protein expression observed in the tumorous epithelium was high in 52/97 (53.6%) of the studied cases, moderate in 20/97 (20.6%), and weak in 5/97 (5.22%) of the cases, and there was strong stromal expression in 34.02% of the tumors. Syndecan-1 expression was statistically correlated to VEGF expression in tumor (p=0.001) and vessels (p=0.007). In addition, there was a borderline correlation between syndecan-1 expression and tenascin (p=0.053). Patients with weak staining reaction had a more unfavorable prognosis (p=0.032) in univariate analysis. These results indicate the implication of syndecan-1 in the remodeling and angiogenesis of colorectal cancer tissue, through interaction with other extracellular matrix components and VEGF, probably influencing the tumor progression and aggressiveness.

Citing Articles

Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.

Muendlein A, Severgnini L, Decker T, Heinzle C, Leiherer A, Geiger K Front Oncol. 2022; 12:1045995.

PMID: 36353562 PMC: 9638102. DOI: 10.3389/fonc.2022.1045995.


Tumor-infiltrating plasma cells are the promising prognosis marker for esophageal squamous cell carcinoma.

Yao C, Yu H, Zhou G, Xu J, Gu D, Yin L Esophagus. 2021; 18(3):574-584.

PMID: 33689055 DOI: 10.1007/s10388-021-00828-y.


Loss of expression of Syndecan-1 is associated with Tumor Recurrence, Metastatic Potential, and Poor Survival in patients with Colorectal carcinoma.

Al-Maghrabi J Pak J Med Sci. 2021; 37(1):114-120.

PMID: 33437261 PMC: 7794120. DOI: 10.12669/pjms.37.1.2592.


Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues.

Kind S, Merenkow C, Buscheck F, Moller K, Dum D, Chirico V Dis Markers. 2020; 2019:4928315.

PMID: 31976021 PMC: 6954471. DOI: 10.1155/2019/4928315.


Stromal and epithelial syndecan-1 expression in benign and malignant salivary gland tumors: which is more reflective of behavior?.

Alaeddini M, Yazdani F, Etemad-Moghadam S Braz J Otorhinolaryngol. 2019; 87(2):171-177.

PMID: 31540870 PMC: 9422431. DOI: 10.1016/j.bjorl.2019.07.006.